Consumer Engagement


Health consumers referred here are patients and potential patients, carers, organisations representing consumers’ interests, members of the public who are targets of health promotion programs and groups asking for research because they believe that they have been exposed to potentially harmful circumstances, products or services.1

To ensure CONCERT delivers best practice and good translational research outcomes to the cancer patients, their carers and families, we engage consumers in our translational cancer research. The benefits of the consumer involvement in research are listed below as stated by Cancer Australia:

To consumers:

  • a health service that is more responsive to consumer needs and issues;
  • improved quality and safety in a service that hears the voice of the consumer;
  • empowerment leading to improved health outcomes for involved individuals;
  • involvement and participation leading to peer support and connection among consumers;
  • skills, knowledge and satisfaction for consumers from contributing to change.

To researchers:

  • ensures that issues important to consumers are identified and prioritised;
  • supports the dissemination of research results;
  • helps to translate research findings into clinical practice and implemented within health service delivery;
  • protects against money and resources being wasted on research that has little or no benefit or impact for consumers;
  • and more


  1. NHMRC, (2004) A Model Framework for Consumer and Community Participation in Research. Commonwealth of Australia, Canberra, viewed 30th June 2015. <>

Ingham Cancer Consumer Panel

The Ingham Cancer Consumer Panel consists of local people who have been affected by cancer either as patients or carers.

The initiative is focused on strengthening the consumer involvement in the Institute’s cancer research projects and involves a core group of cancer patients and carers discussing and giving valuable feedback on the Institute’s cancer research projects, enabling researchers to better align their programs with the health concerns of cancer patients.

The panel meets twice a year with researchers (May and November). At the meetings, the researchers present research projects and ideas to the consumers panel and invite their feedback. Where appropriate the panel members are allocated to a relevant research project and provide their ongoing support and feedback on specific research projects.

Read more

Research Projects

Project Title

Principal Investigator (Project Contact Person)

Areas of experience relevant to the project
UTE: A novel strategy to utilise MRI for accurate and efficient radiation treatment planning and guidance

Dr Gary Liney


Reducing the Greatest Uncertainty in Radiotherapy

A/Prof Lois Holloway


Illness Self-Management and Coping Skills Training for Culturally Diverse Patients with Cancer and their Caregivers

Dr Janelle Levesque


Cancer patients and carers
Co-regulation of tumour suppressor pathways by ATM and SMG1.

Dr Tara Roberts


All cancers
Patient perspectives on shared care after colorectal cancer surgery

Dr Lawrence Tan


Colorectal cancer
Dosimaging: Image Guided Radiation Dosimetry

Dr Peter Metcalfe


Pancreatic Cancer : Novel approaches to therapy

Prof Minoti Apte


Pancreatic cancer
Wellness centre

Prof Geoff Delaney


All cancers
Radiotherapy cardiac toxicity study

Dr Eng-Siew Koh


Breast, lymphoma radiotherapy patients
Radiotherapy Data mining

Prof David Thwaites


Radiotherapy, initially lung and head and neck cancers
Understanding the changes from tumour dormancy to metastasis: Development of prognostic tests and identification of potential therapeutic targets to prevent metastasis

A/Prof Therese Becker


Brest cancer
Angiogenesis and aggressive adenocarcinoma of the prostate

 A/Prof Murray Killingsworth


Adenocarcinoma of the prostate, cell biology, correlative light and electron microscopy, image analysis

Analysing the effect of strong magnetic fields on biological dosing for radiotherapy

Dr Tara Roberts

A/Prof Lois Holloway



The role of the Unfolded Protein Response and Chaperone Mediated Autophagy in the biology and drug resistance of Multple Myeloma

Dr Silvia Ling



Genetic mutations in blood diseases and blood cancers

Dr Silvia Ling



The role of PET/CT in the prediction of outcome in lymphoma

Dr Silvia Ling



The role of primary health care in the outcome blood cancers

Dr Silvia Ling



Innovative, non-invasive test assays for detection of oncoming resistance associated AR (Androgen Receptor) changes

A/Prof Therese Becker


 Prostate cancer

Identifying mechanisms of drug resistance in lung cancer

Dr Tara Roberts

 Lung cancer

Research Meetings

May 2014

Dec 2014

May 2015

Upcoming meetings


If you are a cancer patient or carer and would like to be involved, please contact A/Prof Holloway at